Recruitment for M.Pharm, M.Sc as SRF, RESEARCH ASSISTANT at ICMR - NITM
Eligible candidates are invited to appear for written test / interviews for the following temporary posts on 10th April 2017 to be conducted at ICMR – NITM, Belagavi
Achillion Pharmaceuticals, Inc announced that the U.S. Patent and Trademark Office (USPTO) has issued the first U.S. Patent to Achillion resulting from its complement factor D research program. U.S. Patent No. 9,598,446 has been granted with claims to compositions of matter for compounds that inhibit complement factor D activity, a key mediator in the complement alternative pathway (AP).
Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with clinically guided dosing, according to research presented at the American College of Cardiology’s 66th Annual Scientific Session. Researchers said these findings could have implications for a broad population of patients starting warfarin therapy.
Scientists have developed a cheap portable camera that can photograph the retina without administering the dilating pupillary irritating drops. The camera works by first emitting infrared light, iris - the muscle that controls the opening of the pupil - does not react to.